Matches in Nanopublications for { ?s ?p "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP499749.RAKjYtlflifT76ctbhCpVpDUmUGUs-D0ZiRxfi6LpBNfo130_assertion description "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499749.RAKjYtlflifT76ctbhCpVpDUmUGUs-D0ZiRxfi6LpBNfo130_provenance.
- NP499751.RAO2Gn8jIpTpoM1Qp2SWlXEQJ0NKoi90tk6jMCZKpd_Pw130_assertion description "[Studies have shown that mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain are associated with response of lung cancer to gefitinib (Iressa, AstraZeneca Corp., Shanghai, China).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499751.RAO2Gn8jIpTpoM1Qp2SWlXEQJ0NKoi90tk6jMCZKpd_Pw130_provenance.